We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The biotech industry’s push for additional federal stem cell research funding failed July 19 as President Bush used the first veto of his presidency to send the legislation back to likely defeat in Congress.